(Q36849071)

16 August 2017

1 reference

title

Canine obesity: an overview (English)

1 reference

16 August 2017

0 references

Gossellin J

1

1 reference

PubMed ID

17567509

16 August 2017

Wren JA

series ordinal

2

1 reference

PubMed ID

17567509

16 August 2017

Sunderland SJ

series ordinal

3

1 reference

16 August 2017

1 August 2007

1 reference

Journal of Veterinary Pharmacology and Therapeutics

16 August 2017

1 reference

16 August 2017

30 Suppl 1

1 reference

16 August 2017

1-10

1 reference

Gut hormone PYY(3-36) physiologically inhibits food intake

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Pancreatic polypeptide reduces appetite and food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

5-HT2C receptor agonists as potential drugs for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Minireview: Gut peptides regulating satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Effects of neutering on bodyweight, metabolic rate and glucose tolerance of domestic cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Fluoxetine: a randomized clinical trial in the maintenance of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Influence of a high fibre diet on glycaemic control and quality of life in dogs with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Serotonin and norepinephrine reuptake inhibition and eating behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Obesity: occurrence, treatment, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Mitochondrial uncoupling as a target for drug development for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Effect of weight reduction on clinical signs of lameness in dogs with hip osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Ad libitum feeding following ovariectomy in female Beagle dogs: effect on maintenance energy requirement and on blood metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Evaluation of weight loss protocols for dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Hypothalamic control of energy balance: different peptides, different functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

The discovery and status of sibutramine as an anti-obesity drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Comparison of various methods for estimating body fat in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Prevalence of obesity in dogs examined by Australian veterinary practices and the risk factors involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Serotonin releasing agents. Neurochemical, therapeutic and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Effects of sibutramine on resting metabolic rate and weight loss in overweight women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

The satiety effect of cholecystokinin: A progress report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

The gut and regulation of body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.2007.00863.X

10.1111/J.1365-2885.2007.00863.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17567509